Holen Sie sich die Stockscreener-App
21.47
0.05%
0.010
Handel nachbörslich:
21.46
-0.010
-0.05%
Schlusskurs vom Vortag:
$21.46
Offen:
$21.47
24-Stunden-Volumen:
1.03M
Relative Volume:
0.25
Marktkapitalisierung:
$2.22B
Einnahmen:
$158.18M
Nettoeinkommen (Verlust:
$-107.32M
KGV:
-20.60
EPS:
-1.0421
Netto-Cashflow:
$-107.58M
1W Leistung:
+0.14%
1M Leistung:
+0.75%
6M Leistung:
+175.96%
1J Leistung:
+198.61%
1-Tages-Spanne:
$21.46
$21.48
1-Wochen-Bereich:
$21.45
$21.49
52-Wochen-Spanne:
$5.635
$21.49
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Firmenname
Day One Biopharmaceuticals Inc
Sektor
Branche
Telefon
650 484-0899
Adresse
1800 SIERRA POINT PARKWAY, SUITE 200, BRISBANE
Compare DAWN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
21.47 | 2.22B | 158.18M | -107.32M | -107.58M | -1.0421 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2026-01-13 | Fortgesetzt | TD Cowen | Buy |
| 2025-08-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-10-09 | Bestätigt | Needham | Buy |
| 2024-08-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-04-24 | Bestätigt | Needham | Buy |
| 2023-04-25 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-08 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-03 | Eingeleitet | Oppenheimer | Perform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
[SC 14D9/A] Day One Biopharmaceuticals, Inc. Amended Tender Offer Recommendation - Stock Titan
[SC TO-T/A] Day One Biopharmaceuticals, Inc. Amended Third-Party Tender Offer | DAWN SEC FilingForm SC TO-T/A - Stock Titan
Access Industries group tenders Day One (DAWN) 12.9M-share stake at $21.50 - Stock Titan
Day One Biopharmaceuticals stock reaches 52-week high of $21.48 By Investing.com - Investing.com Australia
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year HighHere's What Happened - MarketBeat
Day One Biopharmaceuticals stock reaches 52-week high of $21.48 - Investing.com
Day One Biopharma to be acquired by Servier for $2.5B - MSN
Market Review: Is Day One Biopharmaceuticals Inc forming higher highs and higher lowsTrend Reversal & Trade Opportunity Analysis Reports - baoquankhu1.vn
DAWN Stock Price, Quote & Chart | DAY ONE BIOPHARMACEUTICALS I (NASDAQ:DAWN) - ChartMill
Earnings Recap: How does Day One Biopharmaceuticals Inc compare to its peers2026 Setups & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? - Finviz
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasda - ChartMill
(DAWN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Biotech M&A Spree Helps Lead SBIO to March Gains - ETF Database
Chart Watch: How does Day One Biopharmaceuticals Inc compare to its peers - baoquankhu1.vn
Servier (DAWN) wins FTC early HSR termination, clearing HSR hurdle for tender offer - Stock Titan
HSR waiting period ends for Day One Biopharma (NASDAQ: DAWN) — Offer stays subject to conditions - Stock Titan
Swing Trade: How is Day One Biopharmaceuticals Inc managing supply chain issues2026 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
FMR LLC holds 23,639.69 shares in Day One Biopharmaceuticals (NASDAQ: DAWN) amendment - Stock Titan
JonesTrading Maintains Day One Biopharmaceuticals(DAWN.US) With Hold Rating, Maintains Target Price $21.5 - Moomoo
Aug Levels: Is Day One Biopharmaceuticals Inc a strong growth stock2026 Action & Low Volatility Stock Recommendations - baoquankhu1.vn
Is Day One Biopharmaceuticals Inc a turnaround story2026 Key Highlights & Trade Opportunity Analysis - baoquankhu1.vn
Day One Biopharmaceuticals price target raised to $36 from $32 at JPMorgan - tipranks.com
SG Americas Securities LLC Buys 323,747 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month HighShould You Buy? - MarketBeat
Baker McKenzie Advises Servier on the Acquisition of Day One Biopharmaceuticals for Approximately USD 2.5 Billion - Legal Desire Media and Insights
DAWN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Hennion & Walsh Asset Management Inc. Buys 218,383 Shares of Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat
Breakout Move: Is Day One Biopharmaceuticals Inc a turnaround storyWeekly Stock Summary & Community Verified Trade Signals - baoquankhu1.vn
Earnings Miss: Is Day One Biopharmaceuticals Inc a top pick in the sectorTake Profit & Safe Capital Growth Stock Tips - baoquankhu1.vn
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Down 20.3% in March - MarketBeat
Day One Biopharmaceuticals (DAWN) price target decreased by 10.27% to 21.16 - MSN
(DAWN) Risk Channels and Responsive Allocation - Stock Traders Daily
Are SEM, DAWN, VRE Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
Day One Biopharmaceuticals Executives Sell Shares Amid Legal Firm's Scrutiny of $21.50 Offer - Bitget
Vanguard amends holdings for Day One Biopharmaceuticals (NASDAQ: DAWN), reports 0 shares - Stock Titan
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc.DAWN - The AI Journal
Servier adds exhibit to Day One Biopharma tender offer (DAWN) - Stock Titan
Servier offers $21.50 per share for Day One (NASDAQ: DAWN) in agreed deal - Stock Titan
Servier (DAWN) offers $21.50 in cash to buy Day One Biopharma shares - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Day One Biopha - GuruFocus
Biggest stock movers Friday: MRVL, GAP, DAWN, GPRO, and more - MSN
SunOpta Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of SunOpta Inc.STKL - Business Wire
Servier (DAWN) plans tender offer under March 6, 2026 merger agreement - Stock Titan
Aug Breakouts: Will Day One Biopharmaceuticals Inc stock go up in YEAR2026 Intraday Action & High Conviction Buy Zone Alerts - baoquankhu1.vn
Day One Biopharmaceuticals stock hits 52-week high at $21.44 By Investing.com - Investing.com Australia
Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 1-Year HighShould You Buy? - MarketBeat
Day One Biopharmaceuticals stock hits 52-week high at $21.44 - Investing.com
Glazer Capital (NASDAQ: DAWN) reports 5.6M-share, 5.44% stake - Stock Titan
Take Profit: Is Day One Biopharmaceuticals Inc a strong growth stockStock Surge & AI Driven Stock Reports - baoquankhu1.vn
Day One Biopharmaceuticals reiterates $225M–$250M OJEMDA revenue target as pipeline expands with Emi-Le integration - MSN
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):